0 Commentarios
0 Acciones
1307 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
- Please log in to like, share and comment!
- Understanding Corticosteroid Therapy in Duchenne Muscular Dystrophy (DMD) TreatmentCorticosteroid therapy is a cornerstone of Duchenne Muscular Dystrophy (DMD) treatment. These medications, such as prednisone and deflazacort, have shown significant benefits in slowing disease progression and prolonging ambulation in individuals with DMD. Corticosteroids work by reducing inflammation and suppressing muscle fiber damage, thus preserving muscle strength and function. However,...0 Commentarios 0 Acciones 1730 Views 0 Vista previa
- A New Hope for DMD: Sarepta’s ELEVIDYS Gene TherapySarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that primarily affects boys, leading to progressive muscle degeneration and weakness. Historically, DMD has been managed through supportive care, steroids, and emerging pharmaceutical therapies, but there has been no cure. The...0 Commentarios 0 Acciones 490 Views 0 Vista previa
- Advances in Duchenne Muscular Dystrophy TreatmentCauses and Mechanism of Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by the absence of dystrophin, a protein that helps keep muscle cells intact. The defective gene that causes DMD is located on the X chromosome, so it primarily affects boys. Girls can be carriers of the defective...0 Commentarios 0 Acciones 774 Views 0 Vista previa
- Breakthroughs in Alzheimer’s Disease Research: What’s on the Horizon?What Does the Future Hold For Gene Therapy in the Duchenne Muscular Dystrophy (DMD) Treatment Market? Duchenne muscular dystrophy (DMD) is a severe, X-linked genetic disorder characterized by progressive muscle degeneration and weakness. Affecting approximately 1 in 3,500 to 5,000 males globally, DMD is caused by mutations in the dystrophin gene, leading to the absence of dystrophin...0 Commentarios 0 Acciones 479 Views 0 Vista previa
- NASH: Meeting the Unmet Challenges in Liver HealthNASH: Meeting the Unmet Challenges in Liver Health Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH) Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease that represents a significant unmet medical need. Characterized by inflammation and damage in the liver, NASH is a severe form of nonalcoholic fatty liver disease (NAFLD), and its prevalence has been steadily increasing...0 Commentarios 0 Acciones 429 Views 0 Vista previa
- Next-Gen Therapeutic Strategies: Nucleic Acids and Gene Therapies for Neuromuscular DisordersNucleic Acids and Gene Therapies in Neuromuscular Disorders: Next-Generation Therapeutic Strategies Neuromuscular disorders (NMDs) are a diverse group of conditions characterized by the progressive degeneration of muscle and nerve function. Among these, Duchenne muscular dystrophy (DMD) stands out as a devastating condition with no cure, resulting from mutations in the dystrophin gene....0 Commentarios 0 Acciones 409 Views 0 Vista previa